Understanding Migraine Infusion Drug Billing for Better Claim Outcomes

A migraine attack can make it hard to do everyday activities. If a patient isn’t responding to oral medications then infusion therapy becomes an essential option, and sometimes a life-changing one. However, the billing aspect is a side that is sometimes overlooked if the clinical aspect is covered. Which is where things get tricky. Billing, coding and practice management for infusion centers is not always an easy task when it comes to reimbursing for a migraine infusion drug.

All of these codes are going to work together with CPT codes, J codes, NDC numbers, and payer-specific policies. If you miss one, your claim is denied. This article breaks down everything you need to know about migraine infusion drug billing so your team can submit cleaner claims and get better outcomes.

 

What Is Migraine Infusion Drug Therapy Today?

When a patient has a severe or otherwise treatment-resistant migraine, they may require migraine infusion therapy. It is usually administered in an infusion center, hospital outpatient department or, sometimes, an emergency setting. The intravenous injection of a migraine drug typically takes place over a specific time duration. Drugs used are dependent on the history, diagnosis and the physician’s practice.

These are commonly used agents include dihydroergotamine (DHE 45), valproate sodium (Depacon), ketorolac (Toradol), metoclopramide (Reglan), magnesium sulfate, and, in some cases, biologics targeting CGRP. All of these medications have billing requirements, a J code and documentation guidelines. It’s important to know each one well, so you can make accurate claims.

 

Common Migraine Infusion Drug Types Billed Often

Various medications are utilized at various phases in the treatment of migraine. Here are the most popular bills listed:

DHE 45 (Dihydroergotamine): One of the most popular medications for refractory migraines. It is documented as J1110 and dose must be carefully recorded.

Depacon (Valproate Sodium): A drug commonly employed for the treatment of migraine, especially in hospitals. It is used under the bill code J0735 and must be supported by medical necessity documentation, particularly if unsuccessful medical treatment(s) are attempted first.

Toradol (Ketorolac): Nonsteroidal anti-inflammatory commonly included in a migraine cocktail. It’s available under J1885 and is used with other agents.

Reglan (Metoclopramide): An antiemetic medication that is prescribed for nausea related to migraines. It is used as an add-on medication in the treatment of migraine; it is billed under the code J2765, meaning it is commonly used for migraine infusion protocols.

Magnesium Sulfate: For migraine sufferers who suffer from a deficiency in magnesium. It is included in the J3475 bill, is one of the simpler drugs to bill and must be dosed appropriately.

There is a unit definition associated with each infusion drug, with a particular code for each drug. One of the most common mistakes that results in a denial or an under payment is billing the right number of units.

 

CPT Codes Used for Migraine Infusion Drug Claims

In addition, you must have the correct CPT codes for the infusion administration beyond the J codes for the drugs. These are the codes that describe clinical activities involved in establishing and administering the infusion. The initial hour of intravenous infusion for therapy or prophylaxis is covered by the primary infusion CPT code 96365. For add-on hours beyond the first 96366 is used for each hour.

If an additional drug is given via the same IV line, then 96367 will be used for the sequential infusion of the new drug. 96368 is used for concurrent infusions. For push injections, but not for drip infusions, 96374 is used for a single push and 96375 is used for a second push of a new drug. The important thing to remember is that the specific CPT code is dependent on how the infusion drug is used, not only what it is. Your nursing notes should show the time of start, stop times, how the delivery was made and the sequence of drugs given. Otherwise the coder will not be able to give the appropriate codes.

 

J Codes for Migraine Infusion Drug Billing Explained

J codes are HCPCS level II codes and are specific to injectable and infusible drugs. The J code provides the information to the payer about the drug being utilized and how much of it was used for billing purposes when a migraine infusion drug was administered.

Here is a reference list for common migraine infusion drugs:

J Code	Medication	Common Billing Use
J3032	Dihydroergotamine (DHE) Injection	Acute migraine treatment by IV or IM infusion
J1885	Ketorolac Tromethamine	Pain relief for severe migraine attacks
J1200	Diphenhydramine	Adjunct therapy to reduce infusion side effects or treat allergic reactions
J2405	Ondansetron	Controls nausea and vomiting associated with migraine or infusion therapy
J0780	Prochlorperazine	Treats migraine-related nausea and headache symptoms
J2765	Metoclopramide	Manages migraine symptoms and nausea during infusion
J3475	Magnesium Sulfate	Used in selected patients with acute or refractory migraine
J0131	Acetaminophen Injection	IV pain management when clinically appropriate

Billing teams are often not aware that there are drugs that don’t have a specific J code. If these are the case, J3490 is the code to use for unclassified drugs and J3590 for unclassified biologics. Almost always these unclassified codes are for a paper claim with supporting documentation that will include the drug name, dose and NDC number. Billing the wrong J code for a migraine infusion drug, or skipping the NDC entirely, is a guaranteed path to a denial or a request for additional information.

 

How NDC Codes Support Migraine Infusion Drug Claims

The National Drug Code (NDC) is an 11-digit number that identifies the drug product used. Some commercial payers (and some Medicaid programs) require that the NDC be on the claim as well as the J code. If you bill for a migraine infusion drug, the NDC should be the same as the one you’ve ordered from your pharmacy or drug cabinet. It should mirror the manufacturer, the level of the medicine and the size of the pack.

The format needed on claims is usually 11 digits in 5-4-2 format, and is always accompanied by the quantity dispensed and the unit of measure qualifier. If an NDC is not entered for the J code billed or is blank if required, it will be rejected or denied. Remember, there can be different NDC numbers for biosimilars and brand-name drugs even if they have the same J code. This should be confirmed on the day of the drug administration, and not at the end of the month.

 

Prior Authorization Process for Migraine Infusion Drug

One of the largest challenges with migraine infusion drug billing is prior authorization. Most commercial insurers will not cover infusion drugs unless it is submitted first, particularly for more expensive drugs or biologicals.

Step 1: Gather Patient and Clinical Information

Start by  gathering the patient’s diagnosis codes, the exact name of the infusion drug that is being requested, and the physician’s clinical notes. Be sure the chart indicates the severity of the migraine and why outpatient oral therapy did not work.

Step 2: Document Prior Treatment Failures

Infusion therapy is typically not covered if the patient has already attempted two to three medicines to prevent the disease. This requirement for step therapy should be explicitly recorded on the chart including dates and outcomes.

Step 3: Prepare the Letter of Medical Necessity

A signed letter of medical necessity should be provided by the physician, explaining the diagnosis and the selected migraine infusion drug and the rationale for its selection. This letter can make or break it for approval.

Step 4: Submit the Prior Authorization Request

The request should be made as early as possible to the payer, preferably 5-7 business days prior to the scheduled infusion. Submit everything needed to support your work in the first submission to prevent back and forth delays.

Step 5: Follow Up Within 48 to 72 Hours

If you don’t get a reply, contact the payer within 48-72 hours. Record all calls including date, time, representative name and reference number.

Step 6: Record the Authorization Number

Record the authorization number in the patient’s file and on the claim, if approved. If you don’t have a valid authorization number on file, then the claim for the infusion drug will be denied every time.

 

Medical Necessity Documentation for Migraine Infusion Drug

Documenting medical necessity isn’t a task to be pushed aside. It’s the backbone of all successful migraine infusion drug claims. If there is no, even if claims are coded properly; they can be denied during an audit. The documentation must include the reason why the oral medication was ineffective or inappropriate. The diagnosis (using the appropriate ICD-10 codes), the selection of the appropriate migraine infusion drug and what the expected clinical outcome is.

Codes G43.001 through G43.919 are the most prevalent codes used for billing migraine for ICD-10. These are organized by type of migraine (with or without aura), intractable or not intractable, and status migrainosus or not. The physician’s notes should be consistent with the codes submitted. But where the claim indicates intractable migraine and the note doesn’t mention that the migraine has proven to be untreatable in the outpatient setting, it can lead to a denial.

 

Common Migraine Infusion Drug Denials and Their Reasons

Denials for migraine infusion drug claims are more predictable in their nature. Raising awareness of them can help your team avoid them.

Wrong J code/missing J code: This is one of the most frequent mistakes, the use of the incorrect J code or the absence of a J code for the migraine infusion drug.

Units billed incorrectly: There’s a unit defined for each J code. A common error is billing 1 unit of J3475 when you actually gave 2,000mg of magnesium sulfate versus giving 4 units.

Without prior authorization number: If the payer requires an authorization number, submitting a claim without one will be denied.

Medical necessity not met: If the medical necessity is not documented, the payer will refuse to approve the use of the migraine infusion drug as medically necessary.

NDC missing or mismatched: Drug claims are now being sent by many payers that require the NDC. If the NDC is not received or is wrong, the automatic denial is triggered.

Bundling errors: There are some infusion services that are combined with the primary CPT code. Denials as they are billed separately without knowing the payer’s bundling rules.

 

Payer Policies Affecting Migraine Drug Reimbursement

Each payer has its own rules for billing for migraine infusion drugs. Coverage policies, fee schedules and required documentation varies among Medicare, Medicaid and commercial insurers. Medicare normally pays claims for drugs (Part B) at 140 percent of the ASP. Commercial payers may reimburse at rates negotiated with the contract, billed charges, or at AWP. Some payers require specific clinical criteria to be adhered to before it will pay for a specific migraine drug.

These criteria can be included in the payer’s Local Coverage Determination or in the individual coverage policy documents. You should invest your time in reading the top payers’ coverage policies. Having an understanding of what each payer expects when you submit the claim will help your team’s footing.

 

How Infusion Billing Services Optimizes Migraine Drug Claims?

At Infusion Billing Services, we specialize in working with infusion providers who bill for complicated drug therapies such as migraine infusion drug treatments. We have knowledge of the intricacies of J code billing, NDC reporting, prior authorization management, and documentation requirements for each payer. All claims are reviewed prior to submission to identify coding errors, missing information and documentation gaps. Denials are dealt with in detail with clinical and coding justification and the appeals process is managed appropriately. Our goal is simple. We want to ensure you are accurately and timely reimbursed for all your claims for migraine infusion drugs.

 

Tips to Improve Migraine Infusion Drug Claim Outcomes

Here are some tips to help increase the likelihood of success with infusion drug claims.

In conclusion, here are some steps your team can take immediately:

• Provide educational training for nursing staff to record infusion start and stop time, drug name, dose and administration technique for all migraine infusion medications administered.
• Check the patient’s prior authorization before each infusion appointment, NOT the day of the appointment.
• Create a drug billing reference sheet containing the J code, NDC and definition of the units of each drug used for migraines that you routinely administer to patients in your facility.
• Recurrent errors identified by audit of claims on a monthly basis.
• Check payer policies at least on an annual basis, as the coverage requirements for migraine infusion drug therapy may change.

Claim denials and lost revenue from migraine drug billing doesn’t have to be a constant occurrence. By employing the proper processes, documentation practices and billing knowledge, your staff can submit cleaner claims and reap the benefits for the practice and for the patients you provide care, as well.

 

Conclusion

There are many different steps involved in billing for migraines and it is important to detail them all. Each one is part of the puzzle to whether or not your claim will be paid or rejected, from choosing an appropriate J code to submitting NDC numbers and getting prior authorization. Thankfully, the majority of denials in this category can be avoided. A consistent billing documentation process, along with payer policies and billing team understanding, can make a significant difference in the outcomes of claims. Infusion Billing Services helps infusion providers to get it right the first time. When migraine infusion drug denials are impacting your revenue, the proper billing support can make a difference.

 

Frequently Asked Questions

Which CPT code covers migraine infusion therapy?

CPT 96365 is for the first hour of intravenous infusion. Hours will be billed at 96366 for additional hours. The appropriate code will be determined by the manner of administration of the drug.

What J code is used for DHE 45?

DHE 45 is sold as a J1110 per 1 mg administered. Properly documented doses must be documented. Claim denials or under payments can result from billing the wrong units.

Is prior authorization always required for migraine infusion?

Typically, payers do not cover migraine infusion drug therapy unless it has been authorized. There are requirements for each payer. Be sure to confirm prior to scheduling the infusion to prevent claim denials.

What ICD-10 codes apply to migraine infusion billing?

Codes used for the migraine depend on the type of migraine: G43.001 through G43.919. The difference between intractable and non-intractable is important. The diagnosis should be consistent with the clinical documentation in the chart.

Why do migraine infusion drug claims get denied?

Typical denials involve the lack of J codes, wrong units, and previous authorization not on file. Other common denials include NDC mismatches, and inadequate medical necessity documentation.

Does Medicare cover migraine infusion drug therapy?

If medical necessity is met, infusion drugs are covered by Medicare Part B. Reimbursement is based on ASP plus 6 percent. Diagnosis must be supported by documentation as must be the treatment plan.

How is magnesium sulfate billed for migraine treatment?

Magnesium sulfate is sold in the pack at $3.475 per 500 mg. You bill 4 units if you give 2000 mg. Before submitting, always double check the dose from the nursing notes.

What happens when a migraine drug lacks a J code?

To code unclassified drugs, use J3490 or unclassified biologics, use J3590. These codes require that a paper claim be submitted. Submit the drug name, dose and NDC number.

How does NDC reporting affect migraine infusion claims?

Many payers mandate that the NDC be sent in with the J code. Any NDC missing or mismatch results in automatic denials. Verify NDC at the time of drug administration.

Can bundling errors affect migraine infusion drug reimbursement?

Yes, separating billing for infusion services will result in denials when the rules of aggregating these services with the date of the infusion service are not understood. The primary CPT code includes some services. Check with payer policies prior to claiming.